Literature DB >> 17406440

Tissue-specific and cell type-specific RNA interference in vivo.

Manjeet K Rao1, Miles F Wilkinson.   

Abstract

RNA interference (RNAi) is an efficient method for silencing genes in cultured cells. Here we describe a simple RNAi approach for silencing genes in a cell type-specific and tissue-specific way in vivo. The approach, which mimics the means by which naturally occurring 'microRNA's are generated, uses a tissue-specific polymerase II promoter to drive the expression of a short hairpin RNA (shRNA) directed against the gene target. The shRNA is cleaved by ubiquitously expressed endonucleases to form an active small interfering RNA of about 22 nt. As a proof of principle, it has been shown that expression of a shRNA directed against the transcription factor Wilms tumor 1 in transgenic mice reduces that protein specifically in nurse cells in the testis. Our transgenic RNAi approach offers a cost-effective means of rapidly (within months) addressing the function(s) of genes of interest in a wide variety of specific cell types and tissues in mice in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406440     DOI: 10.1038/nprot.2006.260

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  15 in total

1.  PSF controls expression of histone variants and cellular viability in thymocytes.

Authors:  Florian Heyd; Kristen W Lynch
Journal:  Biochem Biophys Res Commun       Date:  2011-10-06       Impact factor: 3.575

2.  RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Authors:  Bomi Lee; Urszula T Iwaniec; Russell T Turner; Yi-Wei Lin; Bart L Clarke; Anne Gingery; Li-Na Wei
Journal:  JCI Insight       Date:  2017-04-06

Review 3.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

4.  Signal- and development-dependent alternative splicing of LEF1 in T cells is controlled by CELF2.

Authors:  Michael J Mallory; Jason Jackson; Brittany Weber; Anthony Chi; Florian Heyd; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

5.  Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa.

Authors:  Joaquin Tosi; Javier Sancho-Pelluz; Richard J Davis; Chun Wei Hsu; Kyle V Wolpert; Jesse D Sengillo; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Exp Biol Med (Maywood)       Date:  2011-09-01

Review 6.  Using transgenic modulation of protein synthesis and accumulation to probe protein signaling networks in Arabidopsis thaliana.

Authors:  Sankalpi N Warnasooriya; Beronda L Montgomery
Journal:  Plant Signal Behav       Date:  2011-09

7.  Rhox8 Ablation in the Sertoli Cells Using a Tissue-Specific RNAi Approach Results in Impaired Male Fertility in Mice.

Authors:  Joshua P Welborn; Matthew G Davis; Steven D Ebers; Genna R Stodden; Kanako Hayashi; Joseph L Cheatwood; Manjeet K Rao; James A MacLean
Journal:  Biol Reprod       Date:  2015-05-13       Impact factor: 4.285

8.  Prnp knockdown in transgenic mice using RNA interference.

Authors:  Micaela Gallozzi; Jérome Chapuis; Fabienne Le Provost; Annick Le Dur; Caroline Morgenthaler; Coralie Peyre; Nathalie Daniel-Carlier; Eric Pailhoux; Marthe Vilotte; Bruno Passet; Laetitia Herzog; Vincent Beringue; José Costa; Philippe Tixador; Gaëlle Tilly; Hubert Laude; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2008-03-19       Impact factor: 2.788

9.  Neuroblastoma-specific expression of potential therapeutics cannot be achieved using a promoter region of the NCX (TLX2) gene.

Authors:  A Tivnan; R L Stallings
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

10.  Emotional regulatory function of receptor interacting protein 140 revealed in the ventromedial hypothalamus.

Authors:  S Flaisher-Grinberg; H C Tsai; X Feng; L N Wei
Journal:  Brain Behav Immun       Date:  2014-04-13       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.